• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register

Azilsartan

Product ID A971334
Cas No. 147403-03-0
Purity ≥98%
Product Unit SizeCostQuantityStock
10 mg $81.80 In stock
50 mg $179.90 In stock
250 mg $354.30 In stock
Bulk Quote
Add to Wishlist

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Azilsartan is an angiotensin II receptor antagonist. It may provide a beneficial effect on the mechanisms involved in cardiometabolic disease and insulin sensitizing in cells. Diabetic mice treated with azilsartan had lowered expressions of pro-inflammatory cytokines in brain vessels and lowered diabetes-induced BBB permeability.

Product Info

Cas No.

147403-03-0

Purity

≥98%

Formula

C25H20N4O5

Formula Wt.

456.46

Chemical Name

2-ethoxy-3-[[4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid

IUPAC Name

2-ethoxy-3-[[4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid

Synonym

TAK-536; TAK 536

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

A971334 MSDS PDF

Info Sheet

A971334 Info Sheet PDF

References

Kurtz T, Kajiya T. Differential pharmacology and benefit/risk of azilsartan compared to other sartans. Vasc Health Risk Manag. 2012;8:133-143. PMID: 22399858.

Han J, Tang H, Yao L, et al. Azilsartan protects against hyperglycemia-induced hyperpermeability of the blood-brain barrier. Bioengineered. 2021 Dec;12(1):3621-3633. PMID: 34266350.

Li W, Wang C, Zhang D, et al. Azilsartan ameliorates ox-LDL-induced endothelial dysfunction via promoting the expression of KLF2. Aging (Albany NY). 2021 May 4; 13(9):12996-13005. PMID: 33946046.

Baker W, White W. Azilsartan medoxomil: a new angiotensin II receptor antagonist for treatment of hypertension. Ann Pharmacother. 2011 Dec;45(12):1506-1515. PMID: 22116996.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2023 LKT Laboratories, All Rights Reserved - Products for research use only